Aurora, Copeia Launch English Version of Physician Experience Platform

*EDMONTON, AB –* Aurora Cannabis Inc., in collaboration with German
healthcare technology leader, Copeia, launched the English-language version
of the Physician Experience Platform (PEP). Developed as a peer-to-peer
educational resource for physicians, PEP provides real-world case studies
from doctors using medical cannabis as part of patient care.

The English PEP follows the successful rollout of the German version in
early 2024. With more than 130 anonymized case studies available, the
platform will give healthcare professionals worldwide access to clinical
insights into cannabis-based therapies. Each case includes detailed
information such as patient history, treated symptoms, therapeutic
outcomes, dosage and product data, and documentation of other therapies
before and during the cannabis-based medicine treatment. Healthcare
providers can also search for local product recommendations based on those
used in similar case studies.

The expanded PEP will initially be available to physicians in Canada,
United Kingdom, Poland, Malta, the Czech Republic, Australia, and New
Zealand.

The PEP platform is gated by DocCheck login access, ensuring that only
verified healthcare professionals can view the content. While the
English-language platform will initially be read-only, Aurora and Copeia
are expected to roll out a future version that would allow physicians
worldwide to upload and share case studies, creating a truly international
medical cannabis study database and deepening cross-border clinical
collaboration.
About Aurora Cannabis Inc.

Aurora serves both the medical and consumer markets across Canada, Europe,
Australia, and New Zealand. The Company’s adult-use brand portfolio
includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being and
Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and
Whistler Medical Marijuana Co., as well as international brands, Pedanios,
IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo
Farms Ltd., a North American supplier of propagated agricultural plants.
About Copeia

Founded in 2020, Copeia is a German medical informatics-based technology
innovator developing AI- and data-driven solutions to optimize
cannabis-based care. Its platform and data-rich ecosystem serve as a single
touchpoint for understanding, applying, and reporting on cannabis therapies.